Jebrail Movaffagh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jebrail Movaffagh has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
Bibi Sedigheh Fazly Bazzaz
Department of Medicinal Chemistry, Faculty of Pharmacy, Mashhad University of Medical Science, Mashhad, Iran
5 shared publicationsNafise Amiri
Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
5 shared publicationsElham Pishavar
Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
3 shared publicationsFatemeh Kalalinia
Departments of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
3 shared publicationsMaryam Hashemi
Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad, University of Medical Sciences, Mashhad, Iran; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
3 shared publicationsArezoo Saberi
Mashhad Univ Med Sci, Orthoped Res Ctr, Mashhad, Iran
2 shared publications
Latest Publications
- 2 March 2026
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 114 (3)
Electrospun Silk Fibroin/Poly(Vinyl Alcohol) Nanofibrous Dressings Co‐Loaded With Teicoplanin and Liposomal Curcumin: Fabrication, Physicochemical Characterization, and Antibacterial Performance
Electrospun silk fibroin (SF)/poly(vinyl alcohol) (PVA) nanofibrous mats co‐loaded with teicoplanin (Tp) and nanoliposomal curcumin (LC) were fabricated to combine extracellular matrix (ECM) mimetic architecture with dual antimicrobial and regenerative functionality. Tp and LC were homogeneously incorporated into SF and PVA, respectively, and electrospun under optimized voltage and flow conditions to yield defect‐free fibers. Morphological analysis confirmed a consistent nanofiber diameter and a water uptake of 364.17% ± 42.25%, while in vitro degradation in PBS progressed to 45.74% ± 3.99% mass loss after 28 days. Tensile testing demonstrated a breaking strength of 5.39 MPa, indicating sufficient mechanical integrity for wound application. Drug‐release assays revealed a biphasic profile for Tp—an initial burst of 666.31 ± 6.85 μg/mL within the first 24 h, followed by sustained liberation over 4 weeks—whereas curcumin exhibited a steady release rate. Cytocompatibility studies on dermal fibroblasts showed 80.88% ± 1.60% viability, and hemolysis remained below 0.13% ± 0.03%, confirming hemocompatibility. In antimicrobial evaluations, the composite dressings achieved synergistic antibactericidal activity against Staphylococcus aureus and Pseudomonas aeruginosa , outperforming single‐agent controls. These findings substantiate the T@S/LC@P scaffold as a versatile, infection‐resistant dressing, promising accelerated wound healing and preventing microbial colonization.
- 2 March 2026
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 114 (3)
Electrospun Silk Fibroin/Poly(Vinyl Alcohol) Nanofibrous Dressings Co‐Loaded With Teicoplanin and Liposomal Curcumin: Fabrication, Physicochemical Characterization, and Antibacterial Performance
Electrospun silk fibroin (SF)/poly(vinyl alcohol) (PVA) nanofibrous mats co‐loaded with teicoplanin (Tp) and nanoliposomal curcumin (LC) were fabricated to combine extracellular matrix (ECM) mimetic architecture with dual antimicrobial and regenerative functionality. Tp and LC were homogeneously incorporated into SF and PVA, respectively, and electrospun under optimized voltage and flow conditions to yield defect‐free fibers. Morphological analysis confirmed a consistent nanofiber diameter and a water uptake of 364.17% ± 42.25%, while in vitro degradation in PBS progressed to 45.74% ± 3.99% mass loss after 28 days. Tensile testing demonstrated a breaking strength of 5.39 MPa, indicating sufficient mechanical integrity for wound application. Drug‐release assays revealed a biphasic profile for Tp—an initial burst of 666.31 ± 6.85 μg/mL within the first 24 h, followed by sustained liberation over 4 weeks—whereas curcumin exhibited a steady release rate. Cytocompatibility studies on dermal fibroblasts showed 80.88% ± 1.60% viability, and hemolysis remained below 0.13% ± 0.03%, confirming hemocompatibility. In antimicrobial evaluations, the composite dressings achieved synergistic antibactericidal activity against Staphylococcus aureus and Pseudomonas aeruginosa , outperforming single‐agent controls. These findings substantiate the T@S/LC@P scaffold as a versatile, infection‐resistant dressing, promising accelerated wound healing and preventing microbial colonization.
- Open Access
Fabrication and Characterization of Buforin I-Loaded Electrospun Chitosan/Polyethylene Oxide Nanofibrous Membranes with Antimicrobial Activity for Food Packing Applications
The rising resistance of bacteria to antibiotics has driven the search for new antimicrobial agents. This study focused on encapsulating Buforin I, an antimicrobial peptide, in chitosan/polyethylene oxide (CS-PEO) nanofibers. Buforin I was loaded at a minimum bactericidal concentration (MBC), 10× MBC, and 20× MBC, with assessments on morphology, thermal properties, chemical bonds, crystalline structure, mechanical strength, antimicrobial activity, and cell toxicity. Techniques like differential scanning calorimetry and Fourier-transform infrared spectroscopy confirmed the effective loading of Buforin I in the nanofibers. Scanning electron microscopy showed that Buforin incorporation increased nanofiber diameters. The tensile strength peaked at 20× MBC. Microbial tests indicated that the inhibition zone for nanofibers at 20× MBC surpassed that of commercial antibiotics. Beef coated with CS-PEO nanofibers containing Buforin I demonstrated reduced pH and water activity, alongside lower weight loss during storage. Texture and color analyses revealed that the Buforin I nanofibers helped maintain beef hardness and slowed color degradation compared to control samples. Moreover, thiobarbituric acid levels and total microbial counts in the coated beef were significantly lower than controls (below 3 log CFU/g after 9 days at 4 °C). Thus, these nanofibers may serve as effective antimicrobial packaging agents to delay food spoilage.
Open AccessFabrication and Characterization of Buforin I-Loaded Electrospun Chitosan/Polyethylene Oxide Nanofibrous Membranes with Antimicrobial Activity for Food Packing Applications
The rising resistance of bacteria to antibiotics has driven the search for new antimicrobial agents. This study focused on encapsulating Buforin I, an antimicrobial peptide, in chitosan/polyethylene oxide (CS-PEO) nanofibers. Buforin I was loaded at a minimum bactericidal concentration (MBC), 10× MBC, and 20× MBC, with assessments on morphology, thermal properties, chemical bonds, crystalline structure, mechanical strength, antimicrobial activity, and cell toxicity. Techniques like differential scanning calorimetry and Fourier-transform infrared spectroscopy confirmed the effective loading of Buforin I in the nanofibers. Scanning electron microscopy showed that Buforin incorporation increased nanofiber diameters. The tensile strength peaked at 20× MBC. Microbial tests indicated that the inhibition zone for nanofibers at 20× MBC surpassed that of commercial antibiotics. Beef coated with CS-PEO nanofibers containing Buforin I demonstrated reduced pH and water activity, alongside lower weight loss during storage. Texture and color analyses revealed that the Buforin I nanofibers helped maintain beef hardness and slowed color degradation compared to control samples. Moreover, thiobarbituric acid levels and total microbial counts in the coated beef were significantly lower than controls (below 3 log CFU/g after 9 days at 4 °C). Thus, these nanofibers may serve as effective antimicrobial packaging agents to delay food spoilage.
- Open Access
- 1 May 2024
- Vol. 12 (5) , 380-399
Recent Advances in the Treatment of Spinal Cord Injury
Spinal cord injury (SCI) is a complex, multifaceted, progressive, and yet incurable complication that can cause irreversible damage to the individual, family, and society. In recent years strategies for the management and rehabilitation of SCI besides axonal regeneration, remyelination, and neuronal plasticity of the injured spinal cord have significantly improved. Although most of the current research and therapeutic advances have been made in animal models, so far, no specific and complete treatment has been reported for SCI in humans. The failure to treat this complication has been due to the inherent neurological complexity and the structural, cellular, molecular, and biochemical characteristics of spinal cord injury. In this review, in addition to elucidating the causes of spinal cord injury from a molecular and pathophysiological perspective, the complexity and drawbacks of neural regeneration that lead to the failure in SCI treatment are described. Also, recent advances and cutting-edge strategies in most areas of SCI treatment are presented.
- 1 May 2024
- Vol. 12 (5) , 380-399
Open AccessRecent Advances in the Treatment of Spinal Cord Injury
Spinal cord injury (SCI) is a complex, multifaceted, progressive, and yet incurable complication that can cause irreversible damage to the individual, family, and society. In recent years strategies for the management and rehabilitation of SCI besides axonal regeneration, remyelination, and neuronal plasticity of the injured spinal cord have significantly improved. Although most of the current research and therapeutic advances have been made in animal models, so far, no specific and complete treatment has been reported for SCI in humans. The failure to treat this complication has been due to the inherent neurological complexity and the structural, cellular, molecular, and biochemical characteristics of spinal cord injury. In this review, in addition to elucidating the causes of spinal cord injury from a molecular and pathophysiological perspective, the complexity and drawbacks of neural regeneration that lead to the failure in SCI treatment are described. Also, recent advances and cutting-edge strategies in most areas of SCI treatment are presented.
- 8 October 2023
- Published by Springer Nature in Journal of Polymers and the Environment
- Vol. 32 (4) , 1573-1592
Fabrication and Characterization of Biomimetic Electrospun Cartilage Decellularized Matrix (CDM)/Chitosan Nanofiber Hybrid for Tissue Engineering Applications: Box-Behnken Design for Optimization
- 8 October 2023
- Published by Springer Nature in Journal of Polymers and the Environment
- Vol. 32 (4) , 1573-1592
Fabrication and Characterization of Biomimetic Electrospun Cartilage Decellularized Matrix (CDM)/Chitosan Nanofiber Hybrid for Tissue Engineering Applications: Box-Behnken Design for Optimization
- 31 July 2022
- Published by Elsevier in Journal of Tissue Viability
- Vol. 31 (4) , 649-656
Evaluation of wound-healing efficiency of a functional Chitosan/Aloe vera hydrogel on the improvement of re-epithelialization in full thickness wound model of rat
- 31 July 2022
- Published by Elsevier in Journal of Tissue Viability
- Vol. 31 (4) , 649-656
Evaluation of wound-healing efficiency of a functional Chitosan/Aloe vera hydrogel on the improvement of re-epithelialization in full thickness wound model of rat
- 8 July 2022
- Published by Springer Nature in Macromolecular Research
- Vol. 30 (8) , 527-535
Evaluation of the Efficiency of Chitosan Hydrogel Containing Berberis integerrima Root Extract on a Full-Thickness Skin Wound in a Rat Model
- 8 July 2022
- Published by Springer Nature in Macromolecular Research
- Vol. 30 (8) , 527-535
Evaluation of the Efficiency of Chitosan Hydrogel Containing Berberis integerrima Root Extract on a Full-Thickness Skin Wound in a Rat Model
- 1 December 2021
- Published by Elsevier in Microbial Pathogenesis
- Vol. 161 (Pt B) , 105301
Buforin I an alternative to conventional antibiotics: Evaluation of the antimicrobial properties, stability, and safety
- 1 December 2021
- Published by Elsevier in Microbial Pathogenesis
- Vol. 161 (Pt B) , 105301
Buforin I an alternative to conventional antibiotics: Evaluation of the antimicrobial properties, stability, and safety
- 1 November 2020
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 162, 645-656
Teicoplanin-loaded chitosan-PEO nanofibers for local antibiotic delivery and wound healing
- 1 November 2020
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 162, 645-656
Teicoplanin-loaded chitosan-PEO nanofibers for local antibiotic delivery and wound healing
- 29 October 2020
- Published by Springer Nature in Journal of Polymers and the Environment
- Vol. 29 (4) , 1089-1098
Encapsulation of Ascorbyl Palmitate in Zein by Electrospinning Technique
- 29 October 2020
- Published by Springer Nature in Journal of Polymers and the Environment
- Vol. 29 (4) , 1089-1098
Encapsulation of Ascorbyl Palmitate in Zein by Electrospinning Technique